[ad_1]
Equity traders bet the Remgro-led consortium is likely to return with a higher bid
09 June 2022 – 10:42
UPDATED 09 June 2022 – 23:12
Mediclinic has rebuffed a £2bn (R38bn) takeover offer from a group of investors that includes its biggest shareholder, Remgro, with its shares having their best day in about eight months as equity traders bet that the Johann Rupert-chaired investment heavyweight is likely to return with a higher bid.
Along with shipping company MSC, in late May, Remgro offered 463p a share for the 55.4% it does not already own in SA’s most valuable hospital group, which is also listed in London…
[ad_2]
Source link